XM does not provide services to residents of the United States of America.
S
S

Sanofi


News

Loonie tunes: Canadian dollar looks vulnerable

LIVE MARKETS-Loonie tunes: Canadian dollar looks vulnerable STOXX 600 down 0.2% Healthcare lags GSK, Sanofi fall on RFK Jr. nomination Wall St futures lower Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com LOONIE TUNES: CANADIAN DOLLAR LOOKS VULNERABLE The FX story of the past week has all been about dollar strength, but it's worth keeping an eye on its Canadian neighbour, which h
S
E
F
U
G

Fear over fundamentals

LIVE MARKETS-Fear over fundamentals STOXX 600 down 0.2% Healthcare lags GSK, Sanofi fall on RFK Jr. nomination Wall St futures lower Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com FEAR OVER FUNDAMENTALS Equity analysts at Barclays note that European equities are lagging the U.S.
S
E
F
U
G

Trump not triggering worries about US debt affordability

LIVE MARKETS-Trump not triggering worries about US debt affordability STOXX 600 down 0.3% Healthcare lags GSK, Sanofi fall on RFK Jr. nomination Wall St futures lower Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com TRUMP NOT TRIGGERING WORRIES ABOUT US DEBT AFFORDABILITY Risks of excessive fiscal deficits, fiscal dominance, and a loss of central bank independence are scenarios th
D
S
E
F
S
U
G

Drugmaker stocks slide as Trump taps vaccine skeptic RFK Jr for US health job

UPDATE 7-Drugmaker stocks slide as Trump taps vaccine skeptic RFK Jr for US health job Vaccine skepticism concerns impact biotech investor sentiment Shares of European drug makers fall, along with U.S. companies Analysts worry about RFK Jr.'s influence on HHS agencies Updates throughout with detail on stock moves By Samuel Indyk and Ludwig Burger Nov 15 (Reuters) - Shares of major U.S.
A
G
M
P
P
R
S
C
K
C

European shares end lower on US rate, Trump jitters

UPDATE 2-European shares end lower on US rate, Trump jitters Generali gains after nine-month profit beat Evotec jumps on 2 bln euro buyout offer from Halozyme STOXX 600 down 0.8% Updated at 1654 GMT By Shashwat Chauhan Nov 15 (Reuters) - Europen shares slipped on Friday, weighed down by disappointing earnings, concerns about the impact of U.S. President-elect Donald Trump's policies on global economies and businesses and a jump in Treasury yields.
G
S
E
F
S
G

European pharma stocks slip after Trump taps RFK Jr to lead top US health agency

BUZZ-European pharma stocks slip after Trump taps RFK Jr to lead top US health agency ** Share in healthcare companies drop the most in Europe, hurt by the news that Donald Trump has selected Robert F. Kennedy Jr. , who has previously spread misinformation on vaccines, to lead the country's top health agency ** STOXX 600 Healthcare index .SXDP at -2.09% is the biggest faller among the pan-European indices ** At 1113.76 points, the sub-index is at its lowest in 7 months and is heading for its big
A
G
R
S
U

Healthcare leads Europe lower

LIVE MARKETS-Healthcare leads Europe lower STOXX 600 down 0.6% Healthcare lags GSK, Sanofi fall on RFK Jr. nomination Wall St futures lower Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com HEALTHCARE LEADS EUROPE LOWER A fall in healthcare stocks is leading major European stock indexes lower on Friday, with vaccine markers hit particularly hard after Trump nominated RFK Jr.
G
S
A
E
F
S
U
G

Europe' vaccine makers fall as Trump picks RFK Jr to lead top US health agency

Europe' vaccine makers fall as Trump picks RFK Jr to lead top US health agency LONDON, Nov 15 (Reuters) - Shares in European vaccine-makers fell in early trade on Friday after U.S. President-elect Donald Trump said he had selected Robert F. Kennedy Jr., who has previously spread misinformation on vaccines, to lead the Department of Health and Human Services.
A
G
S

European stock futures head south

LIVE MARKETS-European stock futures head south Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com EUROPEAN STOCK FUTURES HEAD SOUTH European equity markets look set to open the final day of a choppy week in the red, as investors attempt to digest what Trump and his policies might mean for global stocks.
G
S
A
E
F
U
G

Dupixent SBLA Accepted For FDA Review For Treatment Of Chronic Spontaneous Urticaria

BRIEF-Dupixent SBLA Accepted For FDA Review For Treatment Of Chronic Spontaneous Urticaria Nov 15 (Reuters) - Sanofi SA SASY.PA : PRESS RELEASE: DUPIXENT SBLA ACCEPTED FOR FDA REVIEW FOR THE TREATMENT OF CHRONIC SPONTANEOUS URTICARIA FDA DECISION ON DUPIXENT EXPECTED BY APRIL 18, 2025 SAFETY RESULTS IN ALL LIBERTY-CUPID PHASE 3 STUDIES WERE GENERAL
R
S

French and Benelux stocks-Factors to watch

French and Benelux stocks-Factors to watch Nov 15 (Reuters) - Below are company-related news and stories from France and Benelux which could have an impact on the region's markets or individual stocks. AIRBUS AIR.PA : Elon Musk's hugely successful rockets-to-satellites SpaceX venture would raise anti-trust concerns if it had to operate in Europe, the head of aerospace group Airbus said on Thursday .
A
S
F
N
U

Vaccine makers, packaged food cos slide as Trump taps RFK to head health agency

BUZZ-Vaccine makers, packaged food cos slide as Trump taps RFK to head health agency ** Shares of vaccine makers tumbled at the end of Thursday's trading session as U.S. President-elect Donald Trump selected Robert F Kennedy Jr to head the Department of Health and Human Services ** BioNTech BNTX.O , Moderna MRNA.O , Pfizer PFE.N , GSK GSK.N and San
G
P
P
S
K

Viking Global Investors LP Cuts Share Stake In McDonald's, Raises in Nvidia

BRIEF-Viking Global Investors LP Cuts Share Stake In McDonald's, Raises in Nvidia Nov 14 (Reuters) - Viking Global Investors LP : VIKING GLOBAL INVESTORS LP CUTS SHARE STAKE IN AMAZON.COM INC BY 56.4% TO 4.05 MILLION SHARES - SEC FILING VIKING GLOBAL INVESTORS LP DISSOLVES SHARE STAKE IN BROADCOM VIKING GLOBAL INVESTORS LP REPORTS SHARE STAKE OF 1.
A
B
C
G
N
S
S

Zucara Therapeutics Announces Strategic Investment From Sanofi As Part Of US$20 Million Series B Financing

BRIEF-Zucara Therapeutics Announces Strategic Investment From Sanofi As Part Of US$20 Million Series B Financing Nov 12 (Reuters) - Sanofi SA SASY.PA : ZUCARA THERAPEUTICS ANNOUNCES STRATEGIC INVESTMENT FROM SANOFI AS PART OF US$20 MILLION SERIES B FINANCING ZUCARA: SANOFI TO RECEIVE EXCLUSIVE RIGHT OF FIRST NEGOTIATION ZUCARA: PROCEEDS TO FUND RES
S

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales

UPDATE 3-Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales Adds graphic, updates shares, adds conference call details in paragraphs 6 and 15 By Patrick Wingrove Nov 12 (Reuters) - Novavax NVAX.O cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of handing over the rights to sell the shot to French drugmaker Sanofi SASY.PA .
P
S

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales By Patrick Wingrove Nov 12 (Reuters) - Novavax NVAX.O cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of handing over the rights to sell the shot to Sanofi SASY.PA . The U.S. vaccine maker now expects between $175 million and $225 million for full-year sales of its COVID vaccine, its only product on the market, down from the $275 million to $375 million it previously
P
S

Sanofi Consumer Healthcare India Says CFO Surendra Agarwall Resigns

BRIEF-Sanofi Consumer Healthcare India Says CFO Surendra Agarwall Resigns Nov 12 (Reuters) - Sanofi SA SASY.PA : SANOFI CONSUMER HEALTHCARE INDIA LTD - 544250 - ANNOUNCEMENT UNDER REGULATION 30 (LODR)-RESIGNATION OF CHIEF FINANCIAL OFFICER (CFO) SANOFI CONSUMER HEALTHCARE INDIA- CFO SURENDRA AGARWALL RESIGNS Source text: ID:nBSE2wdS0z Further compa
S

US FDA lifts clinical hold on Novavax's combo flu shot

UPDATE 3-US FDA lifts clinical hold on Novavax's combo COVID-flu shot Adds background in paragraphs 3,9 and 10, updates shares in paragraph 2 Nov 11 (Reuters) - The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's NVAX.O COVID-influenza and its standalone flu vaccines after a safety concern was found to be unrelated to the combination shot, the company said.
P
S

Italy's Recordati sees no impact from potential US pharma tariffs

UPDATE 1-Italy's Recordati sees no impact from potential US pharma tariffs Adds from paragraph 4 background, CFO quotes By Giancarlo Navach MILAN, Nov 7 (Reuters) - Italian drug maker Recordati RECI.MI is not concerned about potential new U.S. tariffs under president-elect Donald Trump as it expects them to have no impact on its rare diseases business, the company's chief financial officer said on Friday.
R
S

Vaccine makers fall after Trump win

BUZZ-Vaccine makers fall after Trump win ** Shares of vaccine makers fall between 2% to 8% after Donald Trump is elected U.S. president for a second term ** Pfizer PFE.N down 2.4%, Moderna MRNA.O down 5%, Novavax NVAX.O down 7.7%, ** U.S.-listed shares of Sanofi SASY.PA , SNY.O and GSK GSK.L , GSK.N down 3.2% and 2.9% respectively ** Trump recently said he would let former presidential candidate and anti-vaccine advocate Robert F.
G
P
S



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.